Skip to main content
Log in

Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice

  • Short Communication
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

The mechanism of the analgesic effect of nitrous oxide (N2O) has not been completely clarified. Although we have reported that the analgesic effect of N2O was significantly decreased in nociceptin-orphanin FQ (N/OFQ) receptor (NOP)-deficient mice, the effect of nociceptin receptor antagonists on N2O-induced analgesia has not been reported. In this investigation, we examined the effect of the NOP antagonist JTC-801 on N2O-induced analgesia in 129Sv mice by the writhing test and tail flick test, and demonstrated that the analgesic effect of N2O was suppressed by the intraperitoneal administration of JTC-801.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Guo TZ, Poree L, Golden W, Stein J, Fujinaga M, Maze M. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat. Anesthesiology. 1996;85:846–852.

    Article  PubMed  CAS  Google Scholar 

  2. Fang F, Guo TZ, Davies MF, Maze M. Opiate receptors in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats. Eur J Pharmacol. 1997;336:137–141.

    Article  PubMed  CAS  Google Scholar 

  3. Zhang C, Davies MF, Guo TZ, Maze M. The analgesic action of nitrous oxide is dependent on the release of norepinephrine in the dorsal horn of the spinal cord. Anesthesiology. 1999;91:1401–1407.

    Article  PubMed  CAS  Google Scholar 

  4. Fujinaga M, Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 2002;25:167–189.

    Article  PubMed  CAS  Google Scholar 

  5. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 1995;270:792–794.

    Article  PubMed  CAS  Google Scholar 

  6. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M, Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 1995;377:532–535.

    Article  PubMed  CAS  Google Scholar 

  7. Neal CR, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, Watson SJ. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol. 1999;412:563–605.

    Article  PubMed  CAS  Google Scholar 

  8. Neal CR, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Watson SJ. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol. 1999;406:503–547.

    Article  PubMed  CAS  Google Scholar 

  9. Himukashi S, Takeshima H, Koyanagi S, Shichino T, Fukuda K. The involvement of the nociceptin receptor in the antinociceptive action of nitrous oxide. Anesth Analg. 2006;103:738–741.

    Article  PubMed  CAS  Google Scholar 

  10. Pan Z, Hirakawa N, Fields HL. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron. 2000;26:515–522.

    Article  PubMed  CAS  Google Scholar 

  11. King MA, Rossi GC, Chang AH, Williams L, Pasternak GW. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci Lett. 1997;223:113–116.

    Article  PubMed  CAS  Google Scholar 

  12. Tian JH, Xu W, Fang Y, Mogil JS, Grisel JE, Grandy DK, Han JS. Bidirectional modulatory effect of orphanin FQ on morphineinduced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol. 1997;120:676–680.

    Article  PubMed  CAS  Google Scholar 

  13. Zeilhofer HU, Calò G. Nociceptin/orphanin FQ and its receptor-potential targets for pain therapy? J Pharmacol Exp Ther. 2003;306:423–429.

    Article  PubMed  CAS  Google Scholar 

  14. Ozaki S, Kawamoto H, Itoh Y, Miyaji M, Azuma T, Ichikawa D, Nambu H, Iguchi T, Iwasawa Y, Ohta H. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist. Eur J Pharmacol. 2000;402:45–53.

    Article  PubMed  CAS  Google Scholar 

  15. Zaratin PF, Petrone G, Sbacchi M, Garnier M, Fossati C, Petrillo P, Ronzoni S, Giardina GA, Scheideler MA. Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111). J Pharmacol Exp Ther. 2004;308:454–461.

    Article  PubMed  CAS  Google Scholar 

  16. Shinkai H, Ito T, Iida T, Kitao Y, Yamada H, Uchida I. 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity. J Med Chem. 2000;43:4667–4677.

    Article  PubMed  CAS  Google Scholar 

  17. Yamada H, Nakamoto H, Suzuki Y, Ito T, Aisaka K. Pharmacological profiles of a novel opioid receptor-like1 (ORL1) receptor antagonist, JTC-801. Br J Pharmacol. 2002;135:323–332.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Koyama, T., Fukuda, K. Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice. J Anesth 23, 301–303 (2009). https://doi.org/10.1007/s00540-009-0739-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-009-0739-2

Key words

Navigation